Equillium, Inc.

Home » Equillium, Inc.

IPO

Equillium, Inc.

We are a biotechnology company leveraging deep understanding of immunobiology to develop products for severe autoimmune and inflammatory, or immuno-inflammatory, disorders with high unmet medical need

Symbol

EQ

Price Range
$14.00 - $16.00

Final Shares
4,670,000

Anticipated Date
TBD

Underwriters
Jefferies, Leerink Partners, Stifel

To view the prospectus for Equillium, Inc. IPO, or any offering listed on ClickIPO,
download the ClickIPO app...

or a prospectus can be requested from G. Price at
ClickIPO Securities, LLC 8601 N Scottsdale Rd, Suite 335, Scottsdale, AZ 85253